Durata Therapeutics - PDFSEARCH.IO - Document Search Engine

Durata Therapeutics
Results: 9

#	Item
1	A BACTERIAL BATTLE The regulatory path to approving new antibiotics has been cleared, but work still remains to rebuild a HEALTHY DRUG PIPELINE was too toxic,” says Glenn Tillotson, a senior partner at the life science Add to Reading List Source URL: cen.acs.org Language: English - Date: 2014-06-12 14:00:02 Antibiotics Glycopeptide antibiotics Gram-positive bacteria Pathogenic bacteria Dalbavancin Antibiotic resistance Durata Therapeutics Quinolone Clostridium difficile Bacteria Biology Microbiology
2	FDA Briefing Document: Anti-Infective Drugs Advisory Committee Meeting Add to Reading List Source URL: www.fda.gov Language: English Health Lipoglycopeptide Amines Durata Therapeutics Clinical trial Methicillin-resistant Staphylococcus aureus Methadone Chemistry Dalbavancin Pharmaceutical sciences
3	Dalbavancin for Injection Anti-Infective Drugs Advisory Committee Durata Therapeutics International B.V. NDA[removed] Add to Reading List Source URL: www.fda.gov Language: English Microbiology Staphylococcaceae Bacterial diseases Eli Lilly and Company Antibiotics Dalbavancin Durata Therapeutics Methicillin-resistant Staphylococcus aureus Lipoglycopeptide Bacteria Biology Glycopeptide antibiotics
4	Introductory Remarks - Anti-Infective Drugs Advisory Committee Meeting for Dalbavancin March 31, 2014 John Alexander, MD, MPH Medical Team Leader, DAIP Add to Reading List Source URL: www.fda.gov Language: English Antibiotics Organofluorides Lipoglycopeptide Biology Linezolid Methicillin-resistant Staphylococcus aureus Microbiology Medicine Glycopeptide antibiotics Durata Therapeutics Dalbavancin
5	CI-1 Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) United States Food and Drug Administration Add to Reading List Source URL: www.fda.gov Language: English Bacterial diseases Glycopeptide antibiotics Staphylococcaceae Tetracycline antibiotics Eli Lilly and Company Durata Therapeutics Dalbavancin Methicillin-resistant Staphylococcus aureus Staphylococcus aureus Bacteria Microbiology Medicine
6	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Anti-Infective Drugs Advisory Committee (AIDAC) Meeting FDA White Oak Campus, Building 31, the Great Room (Rm[removed]White Oak Conference Add to Reading List Source URL: www.fda.gov Language: English Clinical pharmacology Food and Drug Administration Durata Therapeutics Dalbavancin Clinical research Center for Drug Evaluation and Research Skin and skin structure infection Drug discovery Pharmaceutical sciences Pharmacology Medicinal chemistry
7	Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Anti-Infective Drugs Advisory Committee Meeting March 31, 2014 Location: The FDA White Oak Campus, Building 31, The Great Room ( Add to Reading List Source URL: www.fda.gov Language: English Dalbavancin Clinical research Food and Drug Administration Skin and skin structure infection Linezolid Center for Drug Evaluation and Research Chemistry Pharmaceutical sciences Durata Therapeutics
8	Centers for Medicare & Medicaid Services Center for Medicare Management 7500 Security Boulevard Baltimore, Maryland[removed]FY 2015 IPPS New Technology Add-on Town Hall Meeting Add to Reading List Source URL: cms.gov Language: English Durata Therapeutics Dalbavancin Medicaid Medicare Government Health Federal assistance in the United States Healthcare reform in the United States Presidency of Lyndon B. Johnson
9	Centers for Medicare & Medicaid Services Center for Medicare Management 7500 Security Boulevard Baltimore, Maryland[removed]FY 2015 IPPS New Technology Add-on Town Hall Meeting Add to Reading List Source URL: www.cms.gov Language: English - Date: 2014-02-11 16:12:11 Durata Therapeutics Dalbavancin Medicaid Medicare Government Health Federal assistance in the United States Healthcare reform in the United States Presidency of Lyndon B. Johnson